Drawing for BLÜM

USPTO serial 87982530

BLÜM

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BEN, LINDSEY HEATHER
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BLÜM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jonathan A. Hyman

Jonathan A. Hyman KNOBBE MARTENS OLSON & BEAR LLP2040 MAIN STREET, 14TH FLOORIrvine, CA 92614UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Topical analgesics, tinctures, namely, medicinal herb extracts, and herbal anti-inflammatory salves, none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Topical analgesics, tinctures, namely, medicinal herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis and not containing CBD; Topical analgesics, tinctures, namely, medicinal herb extracts, and herbal anti-inflammatory salves, all of the foregoing being comprised in significant part of sterilized hemp seeds, mature stalk and containing no other cannabis ingredients or CBD; Topical analgesics, tinctures, namely, medicinal herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil and not containing any other cannabis ingredients or CBD; Topical analgesics, tinctures, namely, medicinal herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing industrial hemp with a delta-9 THC concentration of not more than 0.3% on a dry weight basis and not containing CBD; Topical analgesics, tinctures, namely, medicinal herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis and not containing CBD; Pharmaceutical preparations, namely, herbal sprays and oils, none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Pharmaceutical preparations, namely, herbal sprays and oils, all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis and not containing CBD; Pharmaceutical preparations, namely, herbal sprays and oils, all of the foregoing being comprised in significant part of sterilized hemp seeds, mature stalk and containing no other cannabis ingredients or CBD; Pharmaceutical preparations, namely, herbal sprays and oils, all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil and not containing any other cannabis ingredients or CBD; Pharmaceutical preparations, namely, herbal sprays and oils, all of the foregoing containing industrial hemp with a delta-9 THC concentration of not more than 0.3% on a dry weight basis and not containing CBD; Pharmaceutical preparations, namely, herbal sprays and oils, all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis and not containing CBD; Balms for medical purposes, none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Balms for medical purposes, all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis and not containing CBD; Balms for medical purposes, all of the foregoing being comprised in significant part of sterilized hemp seeds, mature stalk and containing no other cannabis ingredients or CBD; Balms for medical purposes, all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil and not containing any other cannabis ingredients or CBD; Balms for medical purposes, all of the foregoing containing industrial hemp with a delta-9 THC concentration of not more than 0.3% on a dry weight basis and not containing CBD; Balms for medical purposes, all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis and not containing CBD; Herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain, none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain, all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis and not containing CBD; Herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain, all of the foregoing being comprised in significant part of sterilized hemp seeds, mature stalk and containing no other cannabis ingredients or CBD; Herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain, all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil and not containing any other cannabis ingredients or CBD; Herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain, all of the foregoing containing industrial hemp with a delta-9 THC concentration of not more than 0.3% on a dry weight basis and not containing CBD; and Herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain, all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis and not containing CBDACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 19, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 24, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 24, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 22, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 27, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 27, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 7, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 23, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 23, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Mar 23, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 23, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 23, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 22, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 22, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 22, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 26, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 25, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 25, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 26, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 26, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 27, 2020DPCCDIVISIONAL PROCESSING COMPLETE—
Dec 11, 2019ALIEASSIGNED TO LIE—
Dec 5, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 5, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 4, 2019DRRRDIVISIONAL REQUEST RECEIVED—
Nov 4, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 4, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 4, 2019ERTDTEAS REQUEST TO DIVIDE RECEIVED—
May 3, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 15, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 14, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 14, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 13, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 21, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 21, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 21, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 21, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 21, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 30, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 30, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 27, 2017ALIEASSIGNED TO LIE—
Nov 14, 2017NREVNOTICE OF REVIVAL - E-MAILED—
Nov 13, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 13, 2017PETGPETITION TO REVIVE-GRANTED—
Nov 13, 2017PROATEAS PETITION TO REVIVE RECEIVED—
Sep 22, 2017MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 22, 2017ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 15, 2017CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 15, 2017COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 24, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 14, 2017DOCKASSIGNED TO EXAMINER—
Feb 14, 2017DOCKASSIGNED TO EXAMINER—
Nov 17, 2016DOCKASSIGNED TO EXAMINER—
Nov 17, 2016DOCKASSIGNED TO EXAMINER—
Nov 14, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 11, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance